FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Normal E/A ratio of about 1:2 in an elderly patient with aortic stenosis and left ventricular hypertrophy is indicative of pseudo-normalization (see Figure 7). PW=pulsed wave; MV DT=mitral valve ...

However, there is another silent condition that often remains unnoticed: aortic stenosis, a heart disease that affects nine ...

TAVR is now FDA approved for use in high, intermediate and low surgical risk patients with severe aortic stenosis. Low risk was defined as a predicted 30-day mortality of 3% or less for 30 days ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

The Evolut Low Risk Trial was a randomized ... and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J.

In principle, the blood volume passing through a stenotic valve (aortic stenosis) is equal to the blood volume proximal to the stenosis or in the LVOT (Figure 4). The stroke volume is equal to ...

Medtronic plc, a global leader in healthcare technology, announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial ... alternative to surgery for patients with severe aortic ...